Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 79

1.

Predictors of one-year mortality after hospitalization for an exacerbation of COPD.

Esteban C, Castro-Acosta A, Alvarez-Martínez CJ, Capelastegui A, López-Campos JL, Pozo-Rodriguez F.

BMC Pulm Med. 2018 Jan 25;18(1):18. doi: 10.1186/s12890-018-0574-z.

2.

Age-related differences in management and outcomes in hospitalized healthy and well-functioning bacteremic pneumococcal pneumonia patients: a cohort study.

Ruiz LA, España PP, Gómez A, Bilbao A, Jaca C, Arámburu A, Capelastegui A, Restrepo MI, Zalacain R.

BMC Geriatr. 2017 Jun 20;17(1):130. doi: 10.1186/s12877-017-0518-0.

3.

Validity Study of Catalan, Galician and Basque Language Versions of the COPD Assessment Test and Equivalence With the Spanish Version.

Agustí A, Fernández-Villar A, Capelastegui A, García-Losa M, Velasco B, Sánchez G.

Arch Bronconeumol. 2017 Jun;53(6):311-317. doi: 10.1016/j.arbres.2016.10.003. Epub 2016 Dec 13. English, Spanish.

4.

Outcomes of a telemonitoring-based program (telEPOC) in frequently hospitalized COPD patients.

Esteban C, Moraza J, Iriberri M, Aguirre U, Goiria B, Quintana JM, Aburto M, Capelastegui A.

Int J Chron Obstruct Pulmon Dis. 2016 Nov 24;11:2919-2930. eCollection 2016.

5.

Chronic Obstructive Pulmonary Disease Subtypes. Transitions over Time.

Esteban C, Arostegui I, Aburto M, Moraza J, Quintana JM, García-Loizaga A, Basualdo LV, Aramburu A, Aizpiri S, Uranga A, Capelastegui A.

PLoS One. 2016 Sep 9;11(9):e0161710. doi: 10.1371/journal.pone.0161710. eCollection 2016.

6.

Pneumonia presenting with organ dysfunctions: Causative microorganisms, host factors and outcome.

Menéndez R, Montull B, Reyes S, Amara-Elori I, Zalacain R, Capelastegui A, Aspa J, Borderías L, Martín-Villasclaras JJ, Bello S, Alfageme I, Rodríguez de Castro F, Rello J, Molinos L, Ruiz-Manzano J, Torres A.

J Infect. 2016 Nov;73(5):419-426. doi: 10.1016/j.jinf.2016.08.001. Epub 2016 Aug 6.

PMID:
27506395
7.

Duration of Antibiotic Treatment in Community-Acquired Pneumonia: A Multicenter Randomized Clinical Trial.

Uranga A, España PP, Bilbao A, Quintana JM, Arriaga I, Intxausti M, Lobo JL, Tomás L, Camino J, Nuñez J, Capelastegui A.

JAMA Intern Med. 2016 Sep 1;176(9):1257-65. doi: 10.1001/jamainternmed.2016.3633.

PMID:
27455166
8.

Age-related risk factors for bacterial aetiology in community-acquired pneumonia.

Sahuquillo-Arce JM, Menéndez R, Méndez R, Amara-Elori I, Zalacain R, Capelastegui A, Aspa J, Borderías L, Martín-Villasclaras JJ, Bello S, Alfageme I, de Castro FR, Rello J, Molinos L, Ruiz-Manzano J, Torres A.

Respirology. 2016 Nov;21(8):1472-1479. doi: 10.1111/resp.12851. Epub 2016 Jul 14.

PMID:
27417291
9.

Predictors of Severe Sepsis among Patients Hospitalized for Community-Acquired Pneumonia.

Montull B, Menéndez R, Torres A, Reyes S, Méndez R, Zalacaín R, Capelastegui A, Rajas O, Borderías L, Martin-Villasclaras J, Bello S, Alfageme I, Rodríguez de Castro F, Rello J, Molinos L, Ruiz-Manzano J; NAC Calidad Group.

PLoS One. 2016 Jan 4;11(1):e0145929. doi: 10.1371/journal.pone.0145929. eCollection 2016.

10.

Sensitivity, Specificity, and Positivity Predictors of the Pneumococcal Urinary Antigen Test in Community-Acquired Pneumonia.

Molinos L, Zalacain R, Menéndez R, Reyes S, Capelastegui A, Cillóniz C, Rajas O, Borderías L, Martín-Villasclaras JJ, Bello S, Alfageme I, Rodríguez de Castro F, Rello J, Ruiz-Manzano J, Gabarrús A, Musher DM, Torres A.

Ann Am Thorac Soc. 2015 Oct;12(10):1482-9. doi: 10.1513/AnnalsATS.201505-304OC.

PMID:
26288389
11.

Performance of pro-adrenomedullin for identifying adverse outcomes in community-acquired pneumonia.

España PP, Capelastegui A, Mar C, Bilbao A, Quintana JM, Diez R, Esteban C, Bereciartua E, Unanue U, Uranga A.

J Infect. 2015 May;70(5):457-66. doi: 10.1016/j.jinf.2014.12.003. Epub 2014 Dec 11.

PMID:
25499199
12.

Pneumococcal pneumonia: differences according to blood culture results.

Capelastegui A, Zalacain R, Bilbao A, Egurrola M, Iturriaga LA, Quintana JM, Gomez A, Esteban C, España PP.

BMC Pulm Med. 2014 Aug 5;14:128. doi: 10.1186/1471-2466-14-128.

13.

Streptococcus pneumoniae antigen in urine: diagnostic usefulness and impact on outcome of bacteraemic pneumococcal pneumonia in a large series of adult patients.

Zalacain R, Capelastegui A, Ruiz LA, Bilbao A, Gomez A, Uranga A, España PP.

Respirology. 2014 Aug;19(6):936-43. doi: 10.1111/resp.12341. Epub 2014 Jun 26.

14.

Tobacco smoking increases the risk for death from pneumococcal pneumonia.

Bello S, Menéndez R, Antoni T, Reyes S, Zalacain R, Capelastegui A, Aspa J, Borderías L, Martin-Villasclaras JJ, Alfageme I, Rodríguez de Castro F, Rello J, Luis M, Ruiz-Manzano J.

Chest. 2014 Oct;146(4):1029-1037. doi: 10.1378/chest.13-2853.

PMID:
24811098
15.

[Pulmonary Langerhans' cell histiocytosis in adults: an unknown old disease].

Aburto M, Capelastegui A.

Med Clin (Barc). 2014 Nov 18;143(10):444-5. doi: 10.1016/j.medcli.2014.02.020. Epub 2014 Apr 17. Spanish. No abstract available.

PMID:
24747024
16.

Influence of changes in physical activity on frequency of hospitalization in chronic obstructive pulmonary disease.

Esteban C, Arostegui I, Aburto M, Moraza J, Quintana JM, Aizpiri S, Basualdo LV, Capelastegui A.

Respirology. 2014 Apr;19(3):330-8. doi: 10.1111/resp.12239. Epub 2014 Feb 2.

17.

Bacteremic pneumococcal pneumonia in elderly and very elderly patients: host- and pathogen-related factors, process of care, and outcome.

Ruiz LA, Zalacain R, Capelastegui A, Bilbao A, Gomez A, Uranga A, España PP.

J Gerontol A Biol Sci Med Sci. 2014 Aug;69(8):1018-24. doi: 10.1093/gerona/glt288. Epub 2014 Jan 27.

PMID:
24470128
18.

Microbial aetiology of healthcare associated pneumonia in Spain: a prospective, multicentre, case-control study.

Polverino E, Torres A, Menendez R, Cillóniz C, Valles JM, Capelastegui A, Marcos MA, Alfageme I, Zalacain R, Almirall J, Molinos L, Bello S, Rodríguez F, Blanquer J, Dorado A, Llevat N, Rello J; HCAP Study investigators.

Thorax. 2013 Nov;68(11):1007-14. doi: 10.1136/thoraxjnl-2013-203828. Erratum in: Thorax. 2015 Jul;70(7):708.

PMID:
24130227
19.

Predictive factors of severe multilobar pneumonia and shock in patients with influenza.

Garcia Gutierrez S, Quintana JM, Baricot M, Bilbao A, Capelastegui A, Cilla Eguiluz CG, Domínguez A, Castilla J, Godoy P, Delgado-Rodríguez M, Soldevila N, Astray J, Mayoral JM, Martín V, González-Candelas F, Galán JC, Tamames S, Castro-Acosta AA, Garín O, Pumarola T; CIBERESP Cases and Controls in Pandemic Influenza Working Group, Spain.

Emerg Med J. 2014 Apr;31(4):301-7. doi: 10.1136/emermed-2012-202081. Epub 2013 Feb 28.

PMID:
23449891
20.

Utility of two biomarkers for directing care among patients with non-severe community-acquired pneumonia.

España PP, Capelastegui A, Bilbao A, Diez R, Izquierdo F, Lopez de Goicoetxea MJ, Gamazo J, Medel F, Salgado J, Gorostiaga I, Quintana JM; Population Study of Pneumonia (PSoP) Group.

Eur J Clin Microbiol Infect Dis. 2012 Dec;31(12):3397-405. doi: 10.1007/s10096-012-1708-5. Epub 2012 Aug 5.

PMID:
23010902
21.

Etiology of community-acquired pneumonia in a population-based study: link between etiology and patients characteristics, process-of-care, clinical evolution and outcomes.

Capelastegui A, España PP, Bilbao A, Gamazo J, Medel F, Salgado J, Gorostiaga I, Lopez de Goicoechea MJ, Gorordo I, Esteban C, Altube L, Quintana JM; Poblational Study of Pneumonia (PSoP) Group.

BMC Infect Dis. 2012 Jun 12;12:134. doi: 10.1186/1471-2334-12-134.

22.

Compliance with guidelines-recommended processes in pneumonia: impact of health status and initial signs.

Menéndez R, Torres A, Reyes S, Zalacain R, Capelastegui A, Rajas O, Borderías L, Martín-Villasclaras JJ, Bello S, Alfageme I, de Castro FR, Rello J, Molinos L, Ruiz-Manzano J.

PLoS One. 2012;7(5):e37570. doi: 10.1371/journal.pone.0037570. Epub 2012 May 22.

23.

The International Community-Acquired Pneumonia (CAP) Collaboration Cohort (ICCC) study: rationale, design and description of study cohorts and patients.

Myint PK, Kwok CS, Majumdar SR, Eurich DT, Clark AB, España PP, Man SY, Huang DT, Yealy DM, Angus DC, Capelastegui A, Rainer TH, Marrie TJ, Fine MJ, Loke YK.

BMJ Open. 2012 May 21;2(3). pii: e001030. doi: 10.1136/bmjopen-2012-001030. Print 2012.

24.

Score to identify the severity of adult patients with influenza A (H1N1) 2009 virus infection at hospital admission.

Capelastegui A, Quintana JM, Bilbao A, España PP, Garin O, Alonso J, Astray J, Cantón R, Castilla J, Castro A, Delgado-Rodríguez M, Godoy P, Gónzález-Candelas F, Martín V, Mayoral JM, Pumarola T, Tamames S, Soldevila N, Baricot M, Domínguez A; CIBERESP Cases and Controls in Pandemic Influenza Working Group, Spain.

Eur J Clin Microbiol Infect Dis. 2012 Oct;31(10):2693-701. Epub 2012 Apr 24.

PMID:
22526871
25.

Initial management of pneumonia and sepsis: factors associated with improved outcome.

Menéndez R, Torres A, Reyes S, Zalacain R, Capelastegui A, Aspa J, Borderías L, Martín-Villasclaras JJ, Bello S, Alfageme I, de Castro FR, Rello J, Molinos L, Ruiz-Manzano J.

Eur Respir J. 2012 Jan;39(1):156-62. doi: 10.1183/09031936.00188710. Epub 2011 Aug 4.

26.

The health, activity, dyspnea, obstruction, age, and hospitalization: prognostic score for stable COPD patients.

Esteban C, Quintana JM, Aburto M, Moraza J, Arostegui I, España PP, Aizpiri S, Capelastegui A.

Respir Med. 2011 Nov;105(11):1662-70. doi: 10.1016/j.rmed.2011.05.005. Epub 2011 Jun 23.

27.

Development of a decision tree to assess the severity and prognosis of stable COPD.

Esteban C, Arostegui I, Moraza J, Aburto M, Quintana JM, Pérez-Izquierdo J, Aizpiri S, Capelastegui A.

Eur Respir J. 2011 Dec;38(6):1294-300. doi: 10.1183/09031936.00189010. Epub 2011 May 12.

28.

COPD exacerbation: mortality prognosis factors in a respiratory care unit.

Aburto M, Esteban C, Moraza FJ, Aguirre U, Egurrola M, Capelastegui A.

Arch Bronconeumol. 2011 Feb;47(2):79-84. doi: 10.1016/j.arbres.2010.10.012. Epub 2011 Feb 12. English, Spanish.

29.

[Community acquired pneumonia. New guidelines of the Spanish Society of Chest Diseases and Thoracic Surgery (SEPAR)].

Menéndez R, Torres A, Aspa J, Capelastegui A, Prat C, Rodríguez de Castro F; Sociedad Española de Neumología y Cirugía Torácica.

Arch Bronconeumol. 2010 Oct;46(10):543-58. doi: 10.1016/j.arbres.2010.06.014. Epub 2010 Sep 15. Spanish. No abstract available.

30.

[Three-month course of rifampicin and isoniazid for the treatment of latent tuberculous infection].

Salinas C, Pascual Erquicia S, Diez R, Aguirre U, Egurrola M, Altube L, Capelastegui A.

Med Clin (Barc). 2010 Sep 4;135(7):293-9. doi: 10.1016/j.medcli.2010.02.038. Epub 2010 Jun 17. Spanish.

PMID:
20800162
31.

Study of community-acquired pneumonia: incidence, patterns of care, and outcomes in primary and hospital care.

Capelastegui A, España PP, Bilbao A, Gamazo J, Medel F, Salgado J, Gorostiaga I, Esteban C, Altube L, Gorordo I, Quintana JM; Poblational Study of Pneumonia (PSoP) Group.

J Infect. 2010 Nov;61(5):364-71. doi: 10.1016/j.jinf.2010.07.015. Epub 2010 Aug 6.

PMID:
20692290
32.

[Clinical audit of patients admitted to hospital in Spain due to exacerbation of COPD (AUDIPOC study): method and organisation].

Pozo-Rodríguez F, Alvarez CJ, Castro-Acosta A, Melero Moreno C, Capelastegui A, Esteban C, Hernández Carcereny C, López-Campos JL, Izquierdo Alonso JL, López Quílez A, Agustí A; por el Grupo AUDIPOC España.

Arch Bronconeumol. 2010 Jul;46(7):349-57. doi: 10.1016/j.arbres.2010.04.004. Epub 2010 May 31. Spanish.

33.

BODE-Index vs HADO-score in chronic obstructive pulmonary disease: Which one to use in general practice?

Esteban C, Quintana JM, Moraza J, Aburto M, Aguirre U, Aguirregomoscorta JI, Aizpiri S, Basualdo LV, Capelastegui A.

BMC Med. 2010 May 24;8:28. doi: 10.1186/1741-7015-8-28.

34.

[Where do we have to treat patients with community-acquired pneumonia?].

Capelastegui A, Pablo España P.

Med Clin (Barc). 2010 Jun 12;135(2):63-4. doi: 10.1016/j.medcli.2010.03.003. Epub 2010 May 6. Spanish. No abstract available.

PMID:
20451222
35.

Impact of changes in physical activity on health-related quality of life among patients with COPD.

Esteban C, Quintana JM, Aburto M, Moraza J, Egurrola M, Pérez-Izquierdo J, Aizpiri S, Aguirre U, Capelastegui A.

Eur Respir J. 2010 Aug;36(2):292-300. doi: 10.1183/09031936.00021409. Epub 2010 Jan 14.

36.

Validation and comparison of SCAP as a predictive score for identifying low-risk patients in community-acquired pneumonia.

España PP, Capelastegui A, Quintana JM, Bilbao A, Diez R, Pascual S, Esteban C, Zalacaín R, Menendez R, Torres A.

J Infect. 2010 Feb;60(2):106-13. doi: 10.1016/j.jinf.2009.11.013. Epub 2009 Dec 2. Review.

PMID:
19961875
37.

[A year's experience in an intermediate respiratory care unit].

Aburto M, Esteban C, Aguirre U, Egurrola M, Altube L, Moraza FJ, Capelastegui A.

Arch Bronconeumol. 2009 Nov;45(11):533-9. doi: 10.1016/j.arbres.2009.04.015. Epub 2009 Aug 3. Spanish.

38.

Classifying the severity of COPD: are the new severity scales better than the old?

Esteban C, Quintana JM, Egurrola M, Moraza J, Aburto M, Pérez-Izquierdo J, Basualdo LV, Capelastegui A.

Int J Tuberc Lung Dis. 2009 Jun;13(6):783-90.

PMID:
19460257
39.

Predictors of short-term rehospitalization following discharge of patients hospitalized with community-acquired pneumonia.

Capelastegui A, España Yandiola PP, Quintana JM, Bilbao A, Diez R, Pascual S, Pulido E, Egurrola M.

Chest. 2009 Oct;136(4):1079-1085. doi: 10.1378/chest.08-2950. Epub 2009 Apr 24.

PMID:
19395580
40.

Impact of hospitalisations for exacerbations of COPD on health-related quality of life.

Esteban C, Quintana JM, Moraza J, Aburto M, Egurrola M, España PP, Pérez-Izquierdo J, Aguirre U, Aizpiri S, Capelastegui A.

Respir Med. 2009 Aug;103(8):1201-8. doi: 10.1016/j.rmed.2009.02.002. Epub 2009 Mar 9.

41.

Development of a prognostic index for 90-day mortality in patients discharged after admission to hospital for community-acquired pneumonia.

Capelastegui A, España PP, Quintana JM, Bilbao A, Menendez R, Zalacain R, Torres A.

Thorax. 2009 Jun;64(6):496-501. doi: 10.1136/thx.2008.098814. Epub 2009 Feb 22.

PMID:
19237392
42.

Prospective comparison of severity scores for predicting clinically relevant outcomes for patients hospitalized with community-acquired pneumonia.

Yandiola PPE, Capelastegui A, Quintana J, Diez R, Gorordo I, Bilbao A, Zalacain R, Menendez R, Torres A.

Chest. 2009 Jun;135(6):1572-1579. doi: 10.1378/chest.08-2179. Epub 2009 Jan 13.

PMID:
19141524
43.

Declining length of hospital stay for pneumonia and postdischarge outcomes.

Capelastegui A, España PP, Quintana JM, Gallarreta M, Gorordo I, Esteban C, Urrutia I, Bilbao A.

Am J Med. 2008 Oct;121(10):845-52. doi: 10.1016/j.amjmed.2008.05.010.

PMID:
18823851
44.

Predictors of mortality in patients with stable COPD.

Esteban C, Quintana JM, Aburto M, Moraza J, Egurrola M, España PP, Pérez-Izquierdo J, Capelastegui A.

J Gen Intern Med. 2008 Nov;23(11):1829-34. doi: 10.1007/s11606-008-0783-x. Epub 2008 Sep 16.

45.

Pneumonia: criteria for patient instability on hospital discharge.

Capelastegui A, España PP, Bilbao A, Martinez-Vazquez M, Gorordo I, Oribe M, Urrutia I, Quintana JM.

Chest. 2008 Sep;134(3):595-600. doi: 10.1378/chest.07-3039. Epub 2008 May 19.

PMID:
18490403
46.

[Longitudinal incidence of tuberculosis in a cohort of contacts: factors associated with the disease].

Salinas C, Capelastegui A, Altube L, España PP, Díez R, Oribe M, Urrutia I, Aguirre U.

Arch Bronconeumol. 2007 Jun;43(6):317-23. Spanish.

47.

[The safety of magnetic resonance imaging: an analysis based on a review of incidents at the Osatek Center].

Capelastegui A, Fernández-Cantón G, Fernández-Ruanova B.

Radiologia. 2006 Jul-Aug;48(4):225-34. Spanish.

48.

A simple score for assessing stable chronic obstructive pulmonary disease.

Esteban C, Quintana JM, Aburto M, Moraza J, Capelastegui A.

QJM. 2006 Nov;99(11):751-9. Epub 2006 Oct 9.

PMID:
17030529
49.

Development and validation of a clinical prediction rule for severe community-acquired pneumonia.

España PP, Capelastegui A, Gorordo I, Esteban C, Oribe M, Ortega M, Bilbao A, Quintana JM.

Am J Respir Crit Care Med. 2006 Dec 1;174(11):1249-56. Epub 2006 Sep 14.

PMID:
16973986
50.

[Evaluation of clinical practice in patients admitted with community-acquired pneumonia over a 4-year period].

Capelastegui A, España PP, Quintana JM, Gorordo I, Sañudo C, Bilbao A.

Arch Bronconeumol. 2006 Jun;42(6):283-9. Spanish.

Supplemental Content

Loading ...
Support Center